biote Corp.

For the period ended Dec 31, 2024. Filed Mar 14, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 14, 2025

BTMD$1.08-2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations And Comprehensive Income (Loss)

(in thousands, except share and per share amounts)

	Year Ended December 31,
	2024	2023
Revenue:
Product revenue	$192,240	$182,573
Service revenue	4,951	2,787
Total revenue	197,191	185,360
Cost of revenue
Cost of products	55,087	54,246
Cost of services	3,043	3,631
Cost of revenue	58,130	57,877
Selling, general and administrative	107,450	98,826
Income from operations	31,611	28,657
Other income (expense), net:
Interest expense, net	(11,001)	(6,363)
Loss from change in fair value of warrant liability	—	(13,411)
Loss from change in fair value of earnout liabilities	(19,605)	(8,990)
Other income (expense)	11	(16)
Total other income (expense), net	(30,595)	(28,780)
Income (loss) before provision for income taxes	1,016	(123)
Income tax expense	970	2,682
Net Income (loss)	46	(2,805)
Less: Net loss attributable to noncontrolling interest	(3,111)	(6,121)
Net income attributable to biote Corp. stockholders	$3,157	$3,316
Other comprehensive income (loss):
Foreign currency translation adjustments	(15)	8
Other comprehensive income (loss)	(15)	8
Comprehensive income (loss)	$31	$(2,797)
Net income per common share
Basic	$0.09	$0.13
Diluted	$0.09	$0.13
Weighted average common shares outstanding
Basic	34,270,809	25,709,343
Diluted	34,270,809	25,709,343

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.